Viewing nowPralyn Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
Ilhwa Co., Ltd.

MFDS item code 201205825 · Approved 2012.06.22 · Insurance code 640902350
Improvement of peripheral and central neuropathic pain and fibromyalgia, adjunctive treatment for partial seizures in epilepsy.
This medicine is used to treat peripheral and central neuropathic pain in adults and serves as an adjunct for the treatment of partial seizures in epilepsy patients, either with or without secondary generalized symptoms. It also helps to alleviate symptoms of fibromyalgia. Effectively used for these various neurological conditions, it improves the quality of life for patients.
This medication should be taken orally, divided into two doses daily, regardless of food intake. 1. Neuropathic Pain - Peripheral Neuropathic Pain: Start with a dose of 150 mg daily, with an increase to 300 mg daily possible after 3 to 7 days, and further increases to a maximum of 600 mg daily can be made at 7-day intervals as needed. - Central Neuropathic Pain: Start with a dose of 150 mg daily, with an increase to 300 mg daily after one week.
Safety and efficacy data are insufficient for children under 12 years and adolescents aged 12 to 17; hence, administration is not recommended.
This medication may increase the risk of suicidal thoughts or behavior, so any changes in mood or abnormal behavior during treatment should be immediately reported to a healthcare professional. Patients with allergies to any of the ingredients in this medication or with certain genetic lactose intolerance should not take it. Patients with diabetes should be cautious as weight gain may require adjustment of blood glucose-regulating medications. If symptoms of angioedema occur, such as swelling of the face or around the mouth, treatment should be stopped immediately. Older adults are at higher risk of falling or injury due to dizziness or drowsiness, so extra caution is needed during initial doses. If there are blurred vision or changes in vision, patients should consult with their doctor. Sudden discontinuation of this medication can result in withdrawal symptoms like insomnia, headaches, and anxiety, so the dosage should be gradually reduced according to medical advice. Patients with a history of substance abuse should be closely monitored due to the potential for abuse of this medication. Patients with impaired kidney function may need to adjust the dose of this medication. Patients with severe heart disease should consult a doctor before use. Caution is necessary when taking this medication with other central nervous system depressants or opioid analgesics due to an increased risk of respiratory suppression. During early pregnancy, this medication may affect the fetus, so women who are pregnant or planning to become pregnant should consult a doctor before taking it. Women who are breastfeeding should discuss with their healthcare provider whether to discontinue breastfeeding or the medication, as it can be transmitted through breast milk. Activities requiring attention, such as driving or operating machinery, should be avoided until dizziness or drowsiness resolves after taking this medication. In the event of overdose, symptoms such as confusion, drowsiness, and seizures may occur, and treatment such as dialysis may be necessary. Special care should be taken to store this medication safely for children or the elderly, and transferring to another container should be avoided.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination issues
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air, and it is safest to store it at room temperature between 15 and 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication and prevent deterioration.
A hard capsule with a reddish-brown upper part and a white lower part containing white powder.
30 capsules/bottle, 300 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
Ilhwa Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.